Clinical Trial

A Phase 1, Multicenter, Open-label, Non-randomized, Dose-escalation and Backfill Study of KK2223 in Participants With Relapsed or Refractory T-cell Non Hodgkin Lymphoma

Cancer Type

Lymphoma

Protocol Number

202602110

Principal Investigator

Mehta-Shah, Neha

For more information contact us here:

Brief Summary

Protocol Interventions

Learn About Clinical Trials

Clinical trials are research studies that help us find new ways to prevent, diagnose, and treat cancer. If you are interested in participating in a clinical trial, our team will help you find a study that is right for you. Call us to speak with a Siteman care coordinator.